Tiziana life sciences to participate in 2022 biotech showcase virtual investor conference

New york, jan. 06, 2022 (globe newswire) -- tiziana life sciences (nasdaq: tlsa) (“tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announced that senior management will present at the biotech showcase conference and be available for one-on-one meetings throughout the conference. the conference is being held virtually from january 10th -12th and also during january 17th -19th.
TLSA Ratings Summary
TLSA Quant Ranking